Eli Lilly and Co
-
Business
Zepbound could propel Eli Lilly to become the first $1 trillion pharma stock
Eli Lilly is creating a fortress with its diabetes and anti-obesity medications that could position it to become the first…
Read More » -
Business
SPOT, LLY, PLTR, UBS and more
Check out the companies making headlines before the bell. Spotify — The streaming stock popped 7.4% after Spotify reported an…
Read More » -
Business
Treasury yields inch higher ahead of Fed meeting
U.S. Treasury yields were fractionally higher on Monday, as investors look ahead to this week’s Federal Reserve policy meeting. The…
Read More » -
Business
Ozempic effect has hurt a weight loss stock that’s still a top pick
Game-changing anti-obesity medications have posed nothing short of an existential crisis for Weight Watchers parent WW International since they arrived…
Read More » -
Business
Morgan Stanley’s stock playbook for this slowing, ‘late-cycle’ economy
Investors should seek out safer hideaways in the market as economic activity reaches its peak — and defensive sectors, such…
Read More » -
Business
Obesity medicine euphoria warning: Experts tackle ‘miracle drugs’
Two experts see major challenges facing the adoption of new obesity drugs. Dr. Kavita Patel, a physician and NBC News…
Read More » -
Business
Which stocks might be disrupted next by Ozempic and other GLP-1 drugs
Shares of kidney dialysis providers fell sharply Wednesday after Novo Nordisk said a study showed its Ozempic drug could delay…
Read More » -
Business
How much is a good night’s sleep worth? A lot to these stocks
If you’re like many Americans, you probably don’t feel like you are getting enough sleep every night. In fact, some…
Read More »